3-哌啶甲酰胺结构式
|
常用名 | 3-哌啶甲酰胺 | 英文名 | Nipecotamide |
---|---|---|---|---|
CAS号 | 4138-26-5 | 分子量 | 128.172 | |
密度 | 1.1±0.1 g/cm3 | 沸点 | 311.7±31.0 °C at 760 mmHg | |
分子式 | C6H12N2O | 熔点 | 103-106 °C(lit.) | |
MSDS | 中文版 美版 | 闪点 | 142.3±24.8 °C | |
符号 |
GHS07 |
信号词 | Warning |
中文名 | 3-哌啶甲酰胺 |
---|---|
英文名 | nipecotamide |
中文别名 | 3-吡啶酰胺 | 呱啶甲酰胺 |
英文别名 | 更多 |
密度 | 1.1±0.1 g/cm3 |
---|---|
沸点 | 311.7±31.0 °C at 760 mmHg |
熔点 | 103-106 °C(lit.) |
分子式 | C6H12N2O |
分子量 | 128.172 |
闪点 | 142.3±24.8 °C |
精确质量 | 128.094955 |
PSA | 55.12000 |
LogP | -0.99 |
外观性状 | 黄色结晶粉末 |
蒸汽压 | 0.0±0.7 mmHg at 25°C |
折射率 | 1.483 |
储存条件 | 避光,通风干燥处,密封保存 |
稳定性 | 常温常压下稳定 |
计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:2 3.氢键受体数量:2 4.可旋转化学键数量:1 5.互变异构体数量:3 6.拓扑分子极性表面积55.1 7.重原子数量:9 8.表面电荷:0 9.复杂度:114 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:1 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
符号 |
GHS07 |
---|---|
信号词 | Warning |
危害声明 | H315-H319-H335 |
警示性声明 | P261-P305 + P351 + P338 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
危害码 (欧洲) | Xi:Irritant; |
风险声明 (欧洲) | R36/37/38 |
安全声明 (欧洲) | S26-S37/39 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
海关编码 | 2933399090 |
~99% 3-哌啶甲酰胺 4138-26-5 |
文献:SUMITOMO CHEMICAL COMPANY, LIMITED Patent: US2012/123128 A1, 2012 ; Location in patent: Page/Page column 3 ; |
~% 3-哌啶甲酰胺 4138-26-5 |
文献:Fox Journal of Organic Chemistry, 1952 , vol. 17, p. 547,553 |
3-哌啶甲酰胺上游产品 2 | |
---|---|
3-哌啶甲酰胺下游产品 10 | |
海关编码 | 2933399090 |
---|---|
中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Effects of sodium n-dipropylacetate, muscimol hydrobromide and (R,S) nipecotic acid amide on isolation-induced aggressive behavior in mice.
Psychopharmacology 70(3) , 287-90, (1980) An inhibitor of GABA-T (sodium n-dipropylacetate), a GABA agonist (muscimol hydrobromide) and an inhibitor of GABA uptake (R,S) nipecotic acid amide were administered to DBA/2 isolated aggressive mice... |
|
Gabaergic modulation of mouse-killing in the rat.
Psychopharmacology 83(4) , 367-72, (1984) When GABA-potentiating compounds were administered IP to rats with prior experience of mouse-killing behaviour, a reduction of killing was observed with gamma-vinyl GABA (200 and 400 mg/kg) and nipeco... |
|
Relationships between the chemical constitution of carbamoylpiperidines and related compounds, and their inhibition of ADP-induced human blood platelet aggregation.
Thromb. Res. 22(5-6) , 665-80, (1981)
|
piperidine-3-carboxamide |
nipecotinamide |
3-Piperidinecarboxamide |
3-Piperidinecarboxamide,(S) |
piperidine-3-carboxylic acid amide |
3-Carbamoylpiperidine 3-Piperidinecarboxamide |
Nipecotamide |
nipecotic acid amide |
dihydronicotinamide |
3-carboxamidepiperidine |
EINECS 223-962-5 |
HEXAHYDRONICOTINAMIDE |
MFCD00005993 |